Cryoport, Inc. (CYRX)
Stock analysis · NASDAQ · Industrials · Integrated Freight & Logistics
Cryoport, Inc. (CYRX) is a publicly traded company in the Industrials sector. Latest price: $18.64. Market cap $944.10M. Trailing PE -22.73. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Earnings
Proprietary Signals
About Cryoport, Inc.
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Bey…
Valuation
| P/E (TTM) | -22.73× |
|---|---|
| P/S (TTM) | 5.06× |
| P/B | 1.92× |
| PEG | 0.14× |
| P/FCF (TTM) | -46.42× |
| EV / EBITDA | -289.82× |
| EV / Sales | 4.86× |
| Earnings Yield | -3.86% |
| Free Cash Flow Yield | -2.15% |
Fundamentals
| Enterprise Value | $906.85M |
|---|---|
| Revenue (TTM) | $186.45M |
| Net Income (TTM) | -$36.42M |
| Free Cash Flow (TTM) | -$17.79M |
| Net Debt | -$37.25M |
| Working Capital | $239.17M |
| Gross Margin | 47.08% |
| Operating Margin | -21.25% |
| Net Margin | -19.45% |
| Return on Equity | -7.25% |
| Return on Invested Capital | -5.46% |
Peers
Recent News
- Cryoport to Report Third Quarter 2026 Financial Results on November 5, 2026
- Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?
- Cryoport: Strong Pipeline Of Cell And Gene Therapy Approvals
- CryoPort (CYRX) Upgraded to Buy: Here's Why
- Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript
Related
Browse more tickers: sitemap